Oregon Psilocybin Services (OPS) issued first psilocybin manufacturer license since accepting applications earlier this year.
On March 22, 2023, Oregon Health Authority (OHA) announced the granting of the first psilocybin license to a woman-owned business–Satori Farms PDX LLC (1). In 2020, Oregon legalized psilocybin for therapeutic purposes and created the nation’s first regulatory framework for psilocybin services (2). The newly created Oregon Psilocybin Services (OPS) began accepting license applications in January and expects to issue more licenses to laboratories, service centers, and facilitators in the coming months (1).
“We congratulate Tori Armbrust of Satori Farms PDX LLC for being issued the first psilocybin license in Oregon’s history and for representing women leading the way for the emerging psilocybin ecosystem,” said OPS Section Manager Angie Allbee in the OHA announcement (1). “We are committed to fostering an inclusive partnership with our regulated community to ensure safe, effective and equitable psilocybin services throughout the state.”
Information for finding licensed psilocybin service centers and facilitators can be found on the OPS Licensee Directory website.
Earlier this month the first students graduated from training programs to become certified psilocybin therapy facilitators (3).
For an in-depth look at the regulations surrounding Oregon’s legalized psilocybin industry, check out this Cannabis Science and Technology blog entry from Kim Stuck, CEO and founder of Allay Consulting: https://www.cannabissciencetech.com/view/psilocybin-rule-update-oregons-newly-released-regulations
References
Ep 24, Part III: Data Transparency in Cannabis Testing with Yasha Kahn
December 26th 2024In the final part of this episode, Evan Friedmann and Yasha Kahn discuss the need for a national entity to centralize cannabis data collection, moving from snapshot data to continuous updates. They emphasize the importance of accurate lab data and adverse event tracking, suggesting QR codes on packaging to report issues. Yasha suggests harsher consequences for result manipulation and suggests collaboration between state departments and federal entities to support underfunded regulators. They also discuss the potential benefits of off-the-shelf testing and the importance of stability testing. Finally, Yasha shares his top three reading recommendations for the audience.
Ep 24, Part II: Data Transparency in Cannabis Testing with Yasha Kahn
December 12th 2024Evan Friedmann and Yasha Kahn, co-founder of MCR Labs, discuss the discrepancies between current regulations and data on mycotoxins and pesticides in cannabis products. They highlight the need for updated regulations based on new data, emphasizing the importance of accurate testing and labeling. They also discuss the issue of result manipulation, particularly in THC content, and the need for public health officials to address this. Yasha suggests making testing data public to enhance oversight and suggests a national entity to manage this data for better consistency and public safety.